Pharmafile Logo

News and Press Releases

Asymchem welcomes Franck Mevellec as senior director of Business Development

29 May 2024 -- Paris, France --  Asymchem, a leading global CDMO, is excited to announce the appointment of Franck Mevellec as senior director of business development. Franck brings over...

Category: BioManufacturing, Drug Discovery, Pharmaceutical
Posted: May 29, 2024

Asymchem
inquiry@asymchem.com
Asymchem Laboratories (Tianjin) Co., Ltd No. 6 Dongting 3rd Avenue, TEDA Tianjin, 300457, P.R. China

Kindeva Drug Delivery Invests in Second Manufacturing Line for Greener Inhalers at UK Manufacturing Site

6 May 2024 -- Minnesota, US, and Missouri, US -- Kindeva Drug Delivery, a global leader in drug-device combination products, today announced its investment in a second manufacturing line for...

Category: Drug Delivery, Manufacturing and Packing
Posted: May 6, 2024

Kindeva Drug Delivery
ashley.biladeau@edelman.com

University of Liverpool to Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical Study

The UK’s Medical Research Council is funding a 10-patient phase 1 study to deliver rapid personalised treatment for lung cancer patients 3 April 2024 -- Hampton, UK -- Touchlight, a...

Category: Biotechnology, Clinical Trials
Posted: April 3, 2024

Touchlight
info@touchlight.com
Morelands & Riverdale Buildings Lower Sunbury Road Hampton TW12 2ER

Touchlight Awarded Tender to Supply Enzymatic dbDNA to CPI’s RNA Centre of Excellence

28 March 2024 -- Hampton, UK -- Touchlight, an innovation-driven CDMO enabling the development of genetic medicines with its doggybone DNA (dbDNA) technology and leaders in enzymatic DNA production, is...

Category: Biotechnology
Posted: March 28, 2024

Touchlight
info@touchlight.com
Morelands & Riverdale Buildings Lower Sunbury Road Hampton TW12 2ER

Recipharm attains major sustainability milestones

Approval of ambitious Greenhouse Gas emission reduction targets by SBTi Commitment to renewable electricity sourcing to 100.0% by 2024 and to 42.1% GHG emission reduction (Scope 1 and 2) by...

Category: Manufacturing and Packing
Posted: March 26, 2024

Recipharm

Gilbert To Officially Open New Development and GMP Manufacturing Facility

22 March 2024 -- Nottingham, UK -- UK-based contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions was joined by Oxford/AstraZeneca COVID-19 vaccine co-inventor Professor Dame Sarah Gilbert, biotech industry representatives and...

Category: BioManufacturing, Clinical Trials, Manufacturing and Packing
Posted: March 22, 2024

Upperton Pharma Solutions
contact@upperton.com
Albert Einstein Centre, Nottingham Science Park, Nottingham, UK, NG7 2TN

Viroclinics-DDL Changes Name to Cerba Research

14 March 2024 -- Rotterdam, the Netherlands -- Viroclinics-DDL (referred to herein as Cerba Research, the Netherlands), a world leading vaccine and antiviral specialty laboratory providing research and clinical trial...

Category: Biotechnology, Clinical Trials
Posted: March 15, 2024

Cerba Research
Klaartestraat 20, 9052 Ghent, Belgium

Global Clinical Trial Supply Leader partners with Pill Connect to deliver greater confidence in clinical trial outcomes

5 March 2024 -- Manchester, UK -- Pill Connect, the smart dosing device company, today announces its acceptance onto the leading CDMO’s (Contract development and manufacturing organisation) smart packaging supply...

Category: Clinical Trials, Drug Delivery, Logistics
Posted: March 5, 2024

Pill Connect
info@pill-connect.con
125 Deansgate, Manchester, M2 3BY, UK

Vetter Becomes a Member of the German Association of Research-Based Pharmaceutical Companies (vfa)

Globally operating CDMO committed to strengthening Germany as a research and production location  Association grants Vetter extraordinary membership vfa recognises the importance of pharmaceutical service providers in drug development and...

Category: Biotechnology, Pharmaceutical
Posted: January 17, 2024

Vetter
Schützenstrasse 87, 88212 Ravensburg

New partnership aims to advance vaccine against MERS coronavirus

CEPI to invest up to $47m to develop and stockpile a ready reserve of emergency MERS vaccine candidate, VTP-500 VTP-500 project with Barinthus Bio and University of Oxford, UK, uses...

Category: Clinical Trials
Posted: January 2, 2024

Barinthus Biotherapeutics
Unit 6-10 Zeus Building Rutherford Avenue Harwell OX11 0DF

Additional Analytical Laboratory and Spray Drying Investments

5 October 2023 -- New Jersey, US -- Experic, a contract development and manufacturing organisation (CDMO) and clinical supply services company serving the biopharmaceutical industry, announced today the successful completion of...

Category: Manufacturing and Packing
Posted: October 5, 2023

Experic
info@expericservices.com
2 Clarke Drive, Cranbury, NJ 08512

Shionogi Presents New Ensitrelvir Clinical and Real-World Data Reinforcing Potential Across COVID-19 Populations at ESWI 2023

New exploratory analysis of phase 3 SCORPIO-SR study data in Asia suggests that ensitrelvir may reduce the risk of persistent and new late-onset symptoms associated with long COVID-19 over one...

Category: Clinical Trials
Posted: September 20, 2023

SHIONOGI
contact@shionogi.eu
33 Kingsway, London, WC2B 6UF, UK